Equitable Clinical Trial Access for Women & Minorities
The underrepresentation of women and minority groups in clinical trials remains a pressing concern. Discover how a top 10 pharma company is making strides in addressing this disparity by harnessing the power of H1's diversity insights to build an equitable clinical trial for cardiovascular disease.